First Time Loading...
A

Adagio Therapeutics Inc
NASDAQ:ADGI

Watchlist Manager
Adagio Therapeutics Inc
NASDAQ:ADGI
Watchlist
Price: 3.48 USD -3.33% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

ADGI Price Targets Summary
Adagio Therapeutics Inc

There are no price targets for ADGI.
ADGI Lowest Forecast
Wall Street Target
Not Available
ADGI Average Forecast
Wall Street Target
Not Available
ADGI Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Adagio Therapeutics Inc Competitors:
Price Targets
FYB
Formycon AG
137% Upside
300149
ChemPartner PharmaTech Co Ltd
183% Upside
I
IMRX
Immuneering Corp
752% Upside
PHIL
Philogen SpA
34% Upside
FYB
Formycon AG
137% Upside
300149
ChemPartner PharmaTech Co Ltd
183% Upside
I
IMRX
Immuneering Corp
752% Upside
PHIL
Philogen SpA
34% Upside
BPMC
Blueprint Medicines Corp
7% Downside
IMMU
Mendus AB (publ)
174% Upside
9966
Alphamab Oncology
60% Upside
PRLD
Prelude Therapeutics Inc
48% Upside

Revenue
Forecast

Revenue Estimate
Adagio Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Adagio Therapeutics Inc

Operating Income forecast
is not available for
Adagio Therapeutics Inc

Net Income
Forecast

Net Income Estimate
Adagio Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ADGI intrinsic value, competitors valuation, and company profile.
DCF Valuation
ADGI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ADGI stock valuation using valuation multiples.
Wall Street Estimates
ADGI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ADGI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADGI's stock price target?
Not Available

ADGI doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.